• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:徐易德,陈琪,白雪莹,韩亚录,张云霞,常福厚.基于生物信息学手段筛选对肾透明细胞癌具有潜在干预作用的天然活性成分及中草药[J].药学研究,2021,40(5):289-299[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2562次   下载 3256次 本文二维码信息
码上扫一扫!
基于生物信息学手段筛选对肾透明细胞癌具有潜在干预作用的天然活性成分及中草药
徐易德1,陈琪1,白雪莹1,韩亚录1,张云霞1,常福厚1,2,3
字体:加大+|默认|缩小-
(1.内蒙古医科大学药学院,内蒙古 呼和浩特 010000;2.内蒙古自治区新药筛选工程研究中心,内蒙古 呼和浩特 010000;3.内蒙古医科大学新药安全评价研究中心,内蒙古 呼和浩特 010000)
摘要:
目的 应用生物信息学及系统药理学的方法探索可干预肾透明细胞癌的潜在化学成分以及含有目的成分的中草药。方法 首先借助GEO基因表达谱数据分析筛选得到肾透明细胞癌与癌旁正常组织的差异基因,同时分析得到差异基因的生物学功能,接着构建差异基因的蛋白互作网络,进一步分析差异基因的在TCGA及GTEx背景数据库中的表达及预后价值,得到目标基因后借助CTD数据库挖掘与目标基因相关化合物,剔除非天然化合物后经TCMSP工具寻找含有天然化合物的中草药。结果 得到肾透明细胞癌与癌旁正常组织的差异基因共有357个上调基因,353个下调基因,富集生物过程包括氧化还原过程、排泄、对药物的反应等,分子功能包括蛋白质均二聚活性、运输活动、受体结合等,细胞定位在细胞外泌体、质膜的组成部分、顶质膜等。在KEGG信号中富集到PPAR信号通路、碳代谢、甘氨酸,丝氨酸和苏氨酸的代谢等信号通路,利用cytohuba基于degree筛选排名前20的基因为核心基因,有明确差异以及有预后意义的BUB1、C3、KIF20A、RRM2、TOP2A基因确定为目标探究与其相关的化合物72个,包含每种化合物的中草药至少一种。结论 基于生物信息学挖掘到多种中草药可以影响目标基因从而干预肾透明细胞癌。
关键词:  生物信息学  肾透明细胞癌  中草药  网络药理学
DOI:10.13506/j.cnki.jpr.2021.05.002
基金项目:国家自然科学基金(No.81760676);内蒙古自治区自然科学基金(No.2019LH08017)
Based on bioinformatics to explore potential Chinese medicine for intervention in renal clear cell carcinoma
XU Yide1,CHEN Qi1,BAI Xueying1,HAN Yalu1,ZHANG Yunxia1,CHANG Fuhou1,2,3
(1. School of Pharmacy, Inner Mongolia Medical University, Hohhot 010000,China;2. Inner Mongolia Autonomous Region New Drug Screening Engineering Research Center, Hohhot 010000,China;3. New Drug Safety Evaluation Research Center, Inner Mongolia Medical University, Hohhot 010000,China)
Abstract:
Objective Apply bioinformatics and systemic pharmacology methods to explore potential chemical components that can interfere with renal clear cell carcinoma and Chinese herbal medicines containing target components.Methods First, use the GEO database to screen and obtain the differential genes between renal clear cell carcinoma and normal tissues adjacent to the cancer, and analyze the biological functions of the genes at the same time, then construct the protein interaction network of the differential genes, and further analyze the target genes in the TCGA and GTEx background databases The expression and prognostic value of the target gene. After the target is obtained, the CTD database is used to mine the compounds related to the target gene, and the TCMSP tool is used to search for Chinese herbal medicines containing natural compounds after removing the non-natural compounds. Results A total of 357 up-regulated genes and 353 down-regulated genes were obtained between renal clear cell carcinoma and normal tissues adjacent to the cancer. The biological processes of enrichment include redox process, excretion, response to drugs, etc. Molecular functions include protein homodimerization Activity, transport activity, receptor binding, etc., cells are located in exosomes, plasma membrane components, apical plasma membrane, etc. The KEGG signal is enriched in the PPAR signaling pathway, carbon metabolism, glycine, serine and threonine metabolism and other signaling pathways. Using cytohuba to screen the top 20 genes based on degree as core genes, there are clear differences and prognostic significance of BUB1, C3, KIF20A, RRM2, TOP2A genes were identified as the target to explore 72 related compounds, including at least one Chinese herbal medicine for each compound. Conclusion Based on bioinformatics mining, a variety of Chinese herbal medicines can affect target genes and interfere with renal clear cell carcinoma.
Key words:  Bioinformatics  Renal clear cell carcinoma  Chinese herbal medicine  Network pharmacology
今日访问量:2432    总访问量:55338847
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司